c.i. 42510 has been researched along with propofol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, XF; Li, JB; Liu, J; Ni, W | 1 |
Asano, N; Ikemoto, K; Ishiyama, T; Kotoda, M; Matsukawa, T; Mitsui, K; Sato, H; Sessler, DI | 1 |
1 trial(s) available for c.i. 42510 and propofol
Article | Year |
---|---|
The effects of Patent Blue dye on peripheral and cerebral oxyhaemoglobin saturations.
Topics: Aged; Anesthetics, Inhalation; Anesthetics, Intravenous; Artifacts; Breast Neoplasms; Cerebrovascular Circulation; Coloring Agents; Diagnostic Errors; Female; Humans; Methyl Ethers; Middle Aged; Monitoring, Intraoperative; Oximetry; Oxyhemoglobins; Propofol; Rosaniline Dyes; Sevoflurane | 2015 |
1 other study(ies) available for c.i. 42510 and propofol
Article | Year |
---|---|
Effects of propofol on P2X7 receptors and the secretion of tumor necrosis factor-α in cultured astrocytes.
Topics: Adenosine Triphosphate; Animals; Astrocytes; Cells, Cultured; Electrophysiological Phenomena; Enzyme-Linked Immunosorbent Assay; Neuroglia; Neuroprotective Agents; Patch-Clamp Techniques; Propofol; Purinergic P2X Receptor Agonists; Rats; Receptors, Purinergic P2X7; Rosaniline Dyes; Time Factors; Tumor Necrosis Factor-alpha | 2012 |